U.S. Luxury Stock News

NYSEAM:ESP
NYSEAM:ESPElectrical

Espey Mfg. & Electronics (ESP) Non Cash Heavy 25.5% Margin Challenges Bullish Earnings Narratives

Espey Mfg. & Electronics (ESP) has reported another solid set of Q3 2026 numbers, with revenue of about US$11.4 million and basic EPS of roughly US$1.03, supported by trailing 12 month EPS of US$3.95 on revenue of around US$42.2 million. The company has seen quarterly revenue range between US$9.1 million and US$13.6 million over the past six periods, while basic EPS has moved between US$0.66 and US$1.10. This sets up the latest quarter against a backdrop of higher trailing earnings growth and...
NasdaqGS:MXCT
NasdaqGS:MXCTLife Sciences

MaxCyte (MXCT) EPS Loss Narrows In Q1 2026 Challenging Bearish Profitability Narratives

MaxCyte (NasdaqGS:MXCT) opened Q1 2026 with revenue of US$9.7 million and a basic EPS loss of US$0.04, while trailing 12 month figures show revenue of US$32.3 million and a basic EPS loss of US$0.37. The company has seen quarterly revenue move from US$10.4 million in Q1 2025 to US$9.7 million in Q1 2026, with net income moving from a loss of US$10.3 million to a loss of US$4.8 million over the same period. These figures frame the discussion for investors who are focused on how margins develop...
NYSE:CMDB
NYSE:CMDBShipping

Costamare Bulkers Holdings (CMDB) Q1 Profitability Challenges Longstanding Bearish Earnings Narratives

Costamare Bulkers Holdings (NYSE:CMDB) has opened 2026 with Q1 revenue of US$111.5 million, basic EPS of US$0.41 and net income of US$9.9 million, setting a clearer profit picture against a share price of US$19.02. The company has previously reported quarterly revenue figures ranging from US$222.9 million to US$318.9 million and a mix of positive and loss making EPS and net income results, so this quarter slots into a track record that already includes periods of pressure on earnings quality...
NasdaqGS:SNPS
NasdaqGS:SNPSSoftware

Profitable AI Stocks One Debt Free Earner One Quiet Chip Powerhouse

AI spending is no longer just a race to build the biggest models; it is increasingly about which companies can turn that investment into real earnings. With inflation pressures touching everything from fuel to freight, and central banks keeping rates higher for longer, cash generation and pricing power matter more than ever. The Profitable AI Stocks screener focuses on businesses already using AI to support profits rather than just promises. This article highlights 3 stocks from that list...
NasdaqGM:CAMT
NasdaqGM:CAMTSemiconductor

Camtek (CAMT) Q1 2026 EPS Reset Tests Bullish AI Margin Narratives

Camtek (NasdaqGM:CAMT) sets the tone with Q1 2026 earnings Camtek (NasdaqGM:CAMT) opened 2026 with Q1 revenue of US$121.7 million and basic EPS of US$0.68, setting a clear marker for how the year is starting to shape up. The company has seen revenue move from US$117.3 million in Q4 2024 to US$128.1 million in Q4 2025, with basic EPS across those periods ranging from US$0.73 to US$0.78, while trailing 12 month EPS sits at US$1.05 on revenue of US$499.1 million. With a trailing net margin of...
NasdaqCM:PAYS
NasdaqCM:PAYSDiversified Financial

Is Paysign’s (PAYS) Affordability Shift Redefining Its Core Profit Engine?

Paysign, Inc. reported past first-quarter 2026 results on May 12, posting revenue of US$28.04 million and net income of US$5.44 million, with diluted EPS of US$0.09 from continuing operations. The quarter marked a shift as patient affordability programs became Paysign’s largest revenue contributor, reflecting a mix change toward higher-margin pharma offerings. We’ll now examine how this record first quarter and the rise of patient affordability as Paysign’s largest revenue stream affect its...
NasdaqGS:SOLS
NasdaqGS:SOLSChemicals

Solstice Advanced Materials (SOLS) Valuation Check After Q1 Earnings And Updated Guidance

Q1 earnings and guidance put Solstice Advanced Materials (SOLS) in focus Solstice Advanced Materials (SOLS) has come into focus after reporting first quarter 2026 earnings showing revenue of US$991 million and net income of US$85 million, alongside fresh second quarter and full year net sales guidance. See our latest analysis for Solstice Advanced Materials. At a share price of US$86.81, Solstice Advanced Materials has seen a 7 day share price return of 11.64% and a year to date share price...
NYSE:BETA
NYSE:BETAAerospace & Defense

BETA Technologies Advances FAA Programs As Stock Trades Below Valuation Estimates

BETA Technologies (NYSE:BETA) was selected for seven of eight FAA eVTOL Integration Pilot Programs in the past week. The company received a commercial aircraft order from Surf Air Mobility, expanding its confirmed backlog. BETA launched cargo and medical operations and advanced partnerships with GE Aerospace and General Dynamics. The company continued to roll out its nationwide charging network to support electric aviation operations. At a share price of $16.61, NYSE:BETA has had a tough...
NasdaqCM:SLNH
NasdaqCM:SLNHSoftware

Does Soluna Holdings' (SLNH) Modest Shelf Raise Reveal Its Evolving Capital Strategy in Crypto Infrastructure?

Soluna Holdings, Inc. recently closed its April 29, 2026 shelf registration, raising US$2.66 million through the offering of 2,459,400 shares of common stock. This completed shelf registration, alongside ongoing SEC filings, highlights the company’s continued effort to secure funding for its cryptocurrency mining and data center activities. Next, we’ll consider how Soluna’s recent capital raise via this shelf registration closing shapes the company’s broader investment narrative. Uncover the...
NasdaqGM:AIP
NasdaqGM:AIPSoftware

Arteris (AIP) Revenue Growth With Persistent EPS Loss Tests Bullish Narratives In Q1 2026

Arteris (AIP) has opened Q1 2026 with revenue of US$22.9 million and a basic EPS loss of US$0.17, setting the tone for another growth focused but loss making quarter. The company has seen quarterly revenue move from US$16.5 million in Q1 2025 to US$22.9 million in Q1 2026, while basic EPS losses have ranged between US$0.21 and US$0.17 over the same period, which keeps the spotlight firmly on how efficiently that top line is being converted. With revenue expansion set against ongoing losses,...
NYSE:VLN
NYSE:VLNSemiconductor

Why Valens Semiconductor (VLN) Is Up 18.0% After Beating Q1 Targets And Reaffirming 2026 Guidance

Valens Semiconductor recently reported past first-quarter 2026 results, with revenues of US$16.86 million, a net loss of US$8.29 million, and GAAP gross margin of 62.2%, while reiterating full-year revenue guidance of US$75 million to US$77 million. Management highlighted stronger-than-expected demand for its VS3000 and VS6320 chipsets and signaled a more confident outlook for second-half 2026 growth across audio-video and automotive connectivity markets. We’ll now examine how beating Q1...
NYSE:SUN
NYSE:SUNOil and Gas

Should Sunoco’s (SUN) Surging Q1 Revenue and Profit Require Action From Existing Investors?

In the first quarter ended March 31, 2026, Sunoco LP reported sales of US$10.69 billion and net income of US$644 million, up from US$5.18 billion and US$207 million a year earlier, with basic earnings per share from continuing operations rising to US$2.86 from US$1.22. This sharp expansion in both revenue and profit suggests Sunoco converted higher fuel volumes or pricing into much stronger earnings efficiency compared with the prior-year period. Now we’ll examine how this sharp earnings...
NasdaqGS:ZBRA
NasdaqGS:ZBRAElectronic

Zebra Technologies (ZBRA) Margin Compression Challenges Bullish Earnings Narrative After Q1 2026 Results

Q1 2026 earnings snapshot Zebra Technologies (ZBRA) has opened Q1 2026 with revenue of US$1.5b and basic EPS of US$2.75, setting a clear marker for how the year is starting to shape up. The company has seen quarterly revenue move from US$1.31b in Q1 2025 to US$1.50b in Q1 2026, while basic EPS over the same quarters went from US$2.65 to US$2.75. This gives investors a clear view of how the top and bottom lines are tracking year on year. With trailing 12 month net profit margins sitting below...
NYSE:DOCS
NYSE:DOCSHealthcare Services

Doximity Ties Clinical AI To Aledade And New Pharma Search Revenue

Doximity (NYSE:DOCS) has partnered with Aledade to plug its HIPAA-compliant Clinical AI Suite, including Scribe and Ask, into Aledade’s EHR overlay platform. The integration targets value-based primary care and independent practices, aiming to streamline documentation and surface clinical insights at the point of care. Doximity has also begun monetizing its AI-driven search product for pharmaceutical marketers, opening a new revenue channel tied to digital promotion budgets. Doximity,...
NasdaqGS:WAFD
NasdaqGS:WAFDBanks

Is WaFd (WAFD) Fairly Priced After Its 21.2% One Year Share Price Gain

With WaFd on many watchlists, the key question is whether the recent share price reflects a fair deal or if there is still value on the table. At a last close of US$34.59, the stock is down 2.9% over the past week, up 5.7% over the past month, and has returned 21.2% over the past year, which can change how investors think about both upside potential and risk. Recent coverage has focused on WaFd's position in the US regional banking space and how investors are reacting to sector specific...
NasdaqCM:INVZ
NasdaqCM:INVZElectronic

Assessing Innoviz Technologies (INVZ) Valuation After New LiDAR Partnerships And Autonomous Vehicle Progress

Why recent LiDAR partnerships matter for Innoviz Technologies (NasdaqCM:INVZ) Recent announcements around InnovizTwo evaluations set the stage for Innoviz Technologies (NasdaqCM:INVZ), including an on-sensor perception software agreement and a separate letter of intent with LOXO for L4 autonomous delivery vehicles. See our latest analysis for Innoviz Technologies. These new LiDAR evaluation agreements come as momentum has picked up in the short term, with 1 day, 7 day and 30 day share price...
NasdaqGS:CAI
NasdaqGS:CAIBiotechs

A Look At Caris Life Sciences (CAI) Valuation After Recent Growth, Product Launches And Clinical Data Advances

Caris Life Sciences (CAI) is drawing fresh attention after publishing new tumor mutational burden data, rolling out MI Clarity for breast cancer, securing MolDX approval for ChromoSeq, and reporting detailed first quarter 2026 results. See our latest analysis for Caris Life Sciences. The latest run of product launches and clinical data has not yet translated into positive share price momentum, with Caris Life Sciences' share price return falling 12.35% over the past day and 45.55% year to...
NYSE:PKG
NYSE:PKGPackaging

Is Packaging Corporation of America (PKG) Fairly Priced After Steady Multi Year Share Gains?

Wondering if Packaging Corporation of America at around US$218 per share is offering good value right now? This article walks through the key valuation angles so you can decide how the current price stacks up against the fundamentals. The stock has been relatively steady year to date with a 3.4% gain, while returns are up 3.7% over the last month and 16.5% over the last year, as well as 83.5% over three years and 67.8% over five years. Recent news coverage has centered on Packaging...
NasdaqCM:OSS
NasdaqCM:OSSTech

Will Improved Q1 Results and M&A Plans Reshape One Stop Systems' (OSS) AI Edge Narrative?

In the first quarter of 2026, One Stop Systems, Inc. reported revenue of US$8.07 million, up from US$5.21 million a year earlier, with its net loss narrowing to US$0.52 million from US$2.02 million, and management also confirmed it is actively seeking acquisitions supported by a strengthened balance sheet. An interesting aspect of this update is the combination of sharply improved quarterly results, stronger bookings and management’s intention to deploy capital into selective acquisitions to...